# Human Papillomavirus 9-valent Vaccine, Recombinant

NDC: 69497-0102
Generic name: Human Papillomavirus 9-valent Vaccine, Recombinant
Labeler / Manufacturer: MSD Ireland (Carlow)
Product type: LICENSED VACCINE BULK INTERMEDIATE
Marketing category: DRUG FOR FURTHER PROCESSING
Dosage form: INJECTION, SUSPENSION
Routes: —
Marketing started: 20141210



## Active ingredients

- HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN: 40 ug/.5mL
- HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN: 60 ug/.5mL
- HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN: 40 ug/.5mL
- HUMAN PAPILLOMAVIRUS TYPE 31 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL
- HUMAN PAPILLOMAVIRUS TYPE 33 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL
- HUMAN PAPILLOMAVIRUS TYPE 45 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL
- HUMAN PAPILLOMAVIRUS TYPE 52 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL
- HUMAN PAPILLOMAVIRUS TYPE 58 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL
- HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN: 30 ug/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69497-0102"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69497-0102